在新西兰,甲基安非他明危害每周费用为30.5百万新西兰元,尽管药物使用总体下降,但可卡因使用率仍然上升。 Methamphetamine harms cost $30.5M weekly in New Zealand, with rising cocaine use despite overall drug use decline.

新西兰2025年11月的废水药物检测数据显示,甲基安非他明、甲基安非他明和可卡因继续每周造成约3 300万美元的社会危害,尽管非法药物使用总体下降2%。 New Zealand’s November 2025 wastewater drug testing data shows methamphetamine, MDMA, and cocaine continue to cause an estimated $33 million in weekly social harm, despite a 2% overall decline in illicit drug use. 甲基安非他明仍然是最有害的,每周耗资3 050万美元,奥克兰和丰丁湾的流行率很高。 Methamphetamine remains the most harmful, costing $30.5 million weekly, with high levels in Auckland and Bay of Plenty. 甲基安非他明的使用在全国下降了16%,但在一些地区却有所上升,而可卡因的使用则增加了8%,达到每周4.5公斤,主要是在奥克兰和丰蒂湾。 MDMA use dropped 16% nationally but rose in some regions, while cocaine use increased 8% to 4.5 kilograms per week, mainly in Auckland and Bay of Plenty. 覆盖77%人口的国家检测方案揭示了持续存在的区域差异,促使专家敦促雇主保持药物检测、教育和康复方案以保护工作场所。 The national testing program, covering 77% of the population, reveals persistent regional disparities, prompting experts to urge employers to maintain drug testing, education, and rehabilitation programs to protect workplaces.